FHC On a per country example this has led to, for instance, an annual need for 3 million FC2 female condoms in Uganda, and no funding to procure. A need of 1 million female condoms annually in Kenya, and funding for only 230,000. A need of 6 million female condoms annually in Zimbabwe and funding for only 3 million. And these are just some examples of the many countries who do not receive their actual FC2 female condom need on the continent of Africa. Solution Female Health Company would like to propose a partnership with new donors in order to ensure that the need for the FC2 female condom is met in Africa to ensure prevention of HIV/AIDS among the target groups that need it. FHC is committed to providing the training and technical support to the countries and target groups to ensure correct and safe usage of the FC2 female condom, if donors are willing to procure the female condoms that are necessary in these countries. We could even create a specific donor brand for the FC2 female condom, to increase brand recognition for the donor in the region while saving lives together. On Female Health Company The Female Health Company manufactures, markets and sells the FC2 Female Condom. FC2 is the only currently available female-controlled product approved by the U.S. Food and Drug Administration (FDA) and cleared by the World Health Organization (WHO) for purchase by U.N. agencies that provides dual protection against unintended pregnancy and sexually transmitted infections (STIs), including HIV/AIDS. The Company's first generation product was the FC1 Female Condom, a Class III medical device approved by FDA in 1993. The Company's second generation product, FC2, has been available globally since 2007, and in the U.S. since 2009 after it was approved by the FDA as a Class III medical device. To date, FHC has shipped its female condom to over 140 countries worldwide. Currently, there are only two FDA approved and marketed products that prevent the transmission of HIV/AIDS